Do More Tests Provide Greater Reassurance in Follow-Up After Early-Stage Breast Cancer Treatment?

Long-term observation of disease course after initial early-stage breast cancer treatment is important. Many studies report that medical history, physical examination and annual mammography are sufficient during long-term follow-up.
Reliable oncology organizations, journals and research teams state serial blood and radiological tests are unnecessary. Many studies compared history (nodes, surgery, responses to other treatments), examination and annual mammography alone with those plus serial blood and imaging tests, finding no significant difference. A highly trusted British medical journal also published a top 5 list of expensive, commonly used tests and treatments lacking sufficient benefit evidence, including these follow-up tests. Despite this, many doctors continue using them.
Unnecessary testing and treatment harm patients and national economies. Unneeded imaging produces excessive radiation. According to the British Institute of Medicine, radiation is one of the 2 leading environmental factors causing breast cancer, so imaging should be limited to necessity. False positives can also incorrectly diagnose cancer in healthy people. In blood testing, %3 of elevated tumor marker results are reportedly false positives, leading to unnecessary tests, treatments and incorrect diagnoses, harming physical and mental health and the economy. Some studies also show these markers lag 4-6 months in detecting recurrence. Even correct results therefore have questionable usefulness and sensitivity.
Nevertheless, surveys show %80 of patients want intensive blood and imaging follow-up, saying it makes them feel safer. Public perceptions and doctors' attitudes undoubtedly contribute strongly.
In conclusion, excessive tests and treatments should be avoided like any excess. Research continues into ideal levels and approaches to diagnosis, treatment and observation. Many reliable oncology groups, journals and teams particularly advise against serial blood tests and imaging other than mammography after initial early-stage treatment. Definitive conclusions remain premature, but excessive testing and treatment clearly bring more harm than benefit.
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.